| |
|
Headlines:
|
 |
Back
to index
Mitotane (o,p'DDD) - Streptozocin regimen
Abstract: Treatment of hormone-producing adrenocortical cancer with
o,p'DDD and streptozocin.
Three patients with advanced adrenocortical carcinoma were treated with
a combination of intermittent streptozocin and continuous o,p'DDD. Two patients
were treated preoperatively and the primary tumors, initially considered
as inoperable, could be resected after 19 and 5.5 months, respectively.
In the patient with the longer treatment (35 months), lung and lymph node
metastases disappeared and she has no evidence of recurrent disease 6.5
years after start of therapy. One patient was followed by magnetic resonance
imaging (MRI) and urinary steroid secretion. The MRI gave a good visualization
of the tumor. Measurements of relaxation times showed a significant decrease
in T1 values. The urinary steroid profile showed an increased secretion
of 3 beta-hydroxy-5-ene steroids and tetrahydro-11-deoxy-cortisol. Treatment
with streptozocin and o,p'DDD initially increased 16-oxygenation of dehydroepiandrosterone
and androst-5-en-3 beta,17 beta-diol, followed by a decrease in the secretion
of all urinary steroids. The third patient received postoperative treatment
with no effect on metastatic disease in the lungs, she died 9 months after
start of treatment. The therapeutic approach with the combination regimen
of streptozocin and o,p'DDD pretreatment plus aggressive surgery has to
be further evaluated, as well as MRI and urinary steroid profile as methods
to monitor the effect of therapy.
References
Eriksson B, Oberg K, Curstedt T, Hemmingsson A, Johansson H, Lindh E,
Lindgren PG, Thuomas KA, Wilander E, Akerstrom G. Treatment of hormone-producing
adrenocortical cancer with o,p'DDD and streptozocin. Cancer 1987; 59:1398
- 1403.

|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
| Regimen |
|
Mitotane....... 2000 - 4000
mg PO (in 4 divided doses) QD
Streptozocin....... 1000 mg IV days 1 - 5
- followed by 1500 to 2000 mg monthly maintenance |
|
|
| |
|
|
| |
Summary |
|
| |
Overall Response
Rate |
|
| |
Progression
Free Survival |
|
| |
Overall Survival |
|
| |
Toxicity |
|
| |
|
|
|
|